Guangzhou Baiyunshan Pharmaceutical Holdings Company Price Target

Guangzhou Baiyunshan...

SHSE:600332

HK$ 22,92

+ HK$0,07 (0,31%)

22,92 HK$

+HK$0,07 (0,31%)

End-of-day quote: 04/10/2026

Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Value

Analysts currently rate SHSE:600332 as Outperform.

Outperform

Guangzhou Baiyunshan Pharmaceutical Holdings Company Company Info

EPS Growth 5Y

-0,86%

Market Cap

HK$35,48 B

Long-Term Debt

HK$3,53 B

Annual earnings

N/A

Dividend

HK$0,90

Dividend Yield

3,94%

Founded

1997

Industry

Health Care

Country

China

Website

Guangzhou Baiyunshan Pharmaceutical Holdings Company

ISIN Number

CNE100000387

Website

http://www.gybys.com.cn

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$29,59

29.1%

Last Update: 04/11/2026

Analysts: 2

Highest Price Target HK$39,00

Average Price Target HK$29,59

Lowest Price Target HK$20,19

In the last five quarters, Guangzhou Baiyunshan Pharmaceutical Holdings Company’s Price Target has fallen from HK$28,41 to HK$24,33 - a -14,36% decrease. Two analysts predict that Guangzhou Baiyunshan Pharmaceutical Holdings Company’s share price will increase in the coming year, reaching HK$29,59. This would represent an increase of 29,10%.

Top growth stocks in the health care sector (5Y.)

What does Guangzhou Baiyunshan Pharmaceutical Holdings Company do?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical sector. Business Segments The company operates through four segments: Great Southern TCM, Great Health , Great Commerce , and Others segment. Great Southern TCM This segment focuses on the research, development, manufacturing, and sales of Traditional Chinese Medicine (TCM) products, which include both Chinese and Western medicines. The company engages in the production of chemical raw materials, natu...

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical sector.

Business Segments

The company operates through four segments: Great Southern TCM, Great Health , Great Commerce , and Others segment.

Great Southern TCM

This segment focuses on the research, development, manufacturing, and sales of Traditional Chinese Medicine (TCM) products, which include both Chinese and Western medicines. The company engages in the production of chemical raw materials, natural drugs, biological medicines, and other intermediates pivotal in the formulation of medicine. The Great Southern TCM segment has seen consistent growth, with investments aimed at enhancing the quality and availability of TCM products. The company actively cultivates "Diva Brands" and high-potential products within this segment to solidify its market presence.

Great Health

This segment is dedicated to the research and development of health-related products. This includes a wide range of dietary supplements and functional foods aimed at promoting health and well-being. The Great Health segment is an essential part of the company’s strategy, tapping into the growing consumer demand for wellness products. Development initiatives here are designed to align with consumer health trends, emphasizing natural ingredients and scientifically-backed benefits.

Great Commerce

This segment encompasses wholesale, retail, import, and export activities of Western medicine, Chinese medicine, and medical apparatus. As a crucial link in the supply chain, this segment ensures the availability of pharmaceutical products to various consumers and healthcare facilities. The company prioritizes partnerships with healthcare providers to enhance distribution effectiveness and expand market reach.

Others

This segment likely includes ancillary services and operations that support the primary focus on pharmaceuticals.

Business Strategy

The business strategy of the company reflects a multifaceted approach focused on sustainable growth and market leadership. The company prioritizes innovation and efficiency while adapting to the rapidly changing pharmaceutical landscape. The strategy emphasizes several core principles:

Continual Innovation: The company recognizes that innovation is the cornerstone of growth in the pharmaceutical industry. It has established robust research and development capabilities to foster the creation of new and effective products, ensuring that it remains at the forefront of the market.

Market Responsiveness: Understanding consumer needs and market trends is crucial for the company. As part of its strategy, the company monitors market dynamics closely and adjusts its product offerings accordingly, ensuring alignment with market demands for health products that are both effective and safe.

Strengthening Distribution Channels: By enhancing existing distribution pathways and exploring new ones, the company aims to increase the accessibility of its products to various customer segments. Collaborative partnerships with healthcare providers and retailers are key components of this strategy.

Regulatory Compliance: Operating within a regulated environment, the company places great importance on compliance with local and international pharmaceutical regulations to maintain its licenses and good standing.

Products and Services

The company offers an extensive range of products and services within the pharmaceutical sector. This diversified portfolio caters to various health needs and includes:

Chinese Patent Medicines: These are traditional remedies that leverage centuries of herbal medicine expertise. The company invests in refining its formulations and expanding its offerings to meet consumer demands.

Chemical Medicines: The company also engages in the production of multiple chemical-based medications, which address a wide array of health conditions and are crucial for modern healthcare practices.

Health Products: Spurred by the growing consumer inclination towards health and wellness, the company has developed various dietary supplements and functional foods, which are marketed under the Great Health segment. These products are designed to support overall well-being and target specific health concerns.

Medical Apparatus and Instruments: The company’s Great Commerce segment encompasses a wide array of medical equipment and instruments that are critical for healthcare delivery.

Pharmaceutical Distribution Services: Beyond product offerings, the company provides comprehensive distribution services, ensuring that healthcare providers have access to essential medicines and medical supplies.

Geographical Markets Served

The company primarily serves markets within the People’s Republic of China.

Seasonality

Seasonality plays a role in the operations of the company. The demand for certain types of products, particularly those related to health and wellness, can fluctuate throughout the year, influenced by factors such as disease outbreaks, seasonal illnesses, and public health campaigns.

Customers

The company serves a diverse customer base that includes healthcare providers, pharmacies, hospitals, and individual consumers.

Sales and Marketing

The company employs a multi-channel approach to sales and marketing. The company utilizes both traditional and digital marketing strategies to promote its products across various segments of the market. Relationships with healthcare providers, pharmacies, and online retail platforms are paramount for effective distribution, ensuring that products reach consumers in a timely manner.

The company leverages its established distribution networks to enhance product availability, supporting a strong market presence. Direct sales teams also work closely with healthcare professionals to showcase products and educate them about new offerings.

History

The company was founded in 1997. It was incorporated in 1997. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in 2013.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by sectors:** - Pharmaceutical products: approx. 60% - Traditional Chinese medicine: approx. 25% - Health products and others: approx. 15% **TOP 3 markets and their percentage shares:** - China: approx. 70% - Southeast Asia: approx. 15% - North America: approx. 10% Guangzhou...

At which locations are the company’s products manufactured?

**Production Sites:** Guangzhou, China Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited mainly produces its products in Guangzhou, China. The city is a significant hub for the pharmaceutical industry in the region. The company utilizes modern production facilities to manufacture a varie...

What strategy does Guangzhou Baiyunshan Pharmaceutical Holdings Company pursue for future growth?

**Revenue Growth:** 8.5% (2024, estimated) **Profit Growth:** 10.2% (2024, estimated) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited pursues a growth strategy based on several pillars. Firstly, the company is increasingly focusing on research and development of new pharmaceutical...

Which raw materials are imported and from which countries?

**Main Imported Raw Materials:** Herbs, pharmaceutical ingredients, packaging materials **Main Import Countries:** India, Germany, Japan, USA Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited imports a variety of raw materials necessary for the production of their pharmaceutical product...

How strong is the company’s competitive advantage?

**Market share:** 8% in the Chinese pharmaceutical market (2024) **Research and development investments:** 1.5 billion CNY (2024) **Gross margin:** 45% (2024) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has a significant competitive advantage in the Chinese pharmaceutical marke...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Approximately 45% (estimated for 2025 based on historical trends) **Insider Purchases/Sales:** No significant transactions in the last year (2024) The institutional investor share in Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is estimated to be a...

What percentage market share does Guangzhou Baiyunshan Pharmaceutical Holdings Company have?

**Market share of Guangzhou Baiyunshan Pharmaceutical Holdings:** 8% (estimated for 2025) **Top competitors and their market shares:** 1. **Sinopharm Group Co., Ltd.:** 15% 2. **Shanghai Pharmaceuticals Holding Co., Ltd.:** 12% 3. **China Resources Pharmaceutical Group Ltd.:** 10% 4. **Guangzhou Ba...

Is Guangzhou Baiyunshan Pharmaceutical Holdings Company stock currently a good investment?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 7.2% (2024) **Research and Development Ratio:** 5.1% of revenue (2024) **Market Share in China:** 12% (2024) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited recorded solid revenue growth of 8.5% in 2024. This is an indicator of strong...

Does Guangzhou Baiyunshan Pharmaceutical Holdings Company pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.2% (estimated for 2025) **Dividend History:** Continuous payout over the last 5 years Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has regularly distributed dividends in recent years. The dividend yield is estimated to be around 3.2% for 2025, which can be...

New support ticket

Explore

Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Value

Guangzhou Baiyunshan Pharmaceutical Holdings Company Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Guangzhou Baiyunshan Pharmaceutical Holdings Company do?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Value

Guangzhou Baiyunshan Pharmaceutical Holdings Company Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Guangzhou Baiyunshan Pharmaceutical Holdings Company do?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.